These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17616691)

  • 21. [Cell signaling and CDDP resistance].
    Masumoto N; Nakano S
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):424-30. PubMed ID: 9063479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
    Hu S; Hu CP; Liang CH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
    Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.
    Nakagawa H; Ohira M; Hayashi S; Abe S; Saito S; Nagahori N; Monde K; Shinohara Y; Fujitani N; Kondo H; Akiyama S; Nakagawara A; Nishimura S
    Cancer Lett; 2008 Nov; 270(2):295-301. PubMed ID: 18573595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
    Tang C; Luo H; Luo D; Yang H; Zhou X
    Oncol Rep; 2018 Feb; 39(2):611-618. PubMed ID: 29207183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A gene transcription signature of the Akt/mTOR pathway in clinical breast tumors.
    Creighton CJ
    Oncogene; 2007 Jul; 26(32):4648-55. PubMed ID: 17213801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6kinase signaling pathway.
    Eguchi M; Masuda H; Kwon S; Shirakura K; Shizuno T; Ito R; Kobori M; Asahara T
    J Mol Cell Cardiol; 2008 Nov; 45(5):661-9. PubMed ID: 18773906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.
    Ong KW; Teo M; Lee V; Ong D; Lee A; Tan CS; Vathsala A; Toh HC
    Clin Cancer Res; 2009 Sep; 15(17):5350-8. PubMed ID: 19706821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
    Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M
    Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.
    Wu Q; Kiguchi K; Kawamoto T; Ajiki T; Traag J; Carbajal S; Ruffino L; Thames H; Wistuba I; Thomas M; Vasquez KM; DiGiovanni J
    Cancer Res; 2007 Apr; 67(8):3794-800. PubMed ID: 17440093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
    Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
    Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma.
    Tam KH; Yang ZF; Lau CK; Lam CT; Pang RW; Poon RT
    Cancer Lett; 2009 Jan; 273(2):201-9. PubMed ID: 18824293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
    Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
    FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting AKT signaling sensitizes cancer to cellular immunotherapy.
    Hähnel PS; Thaler S; Antunes E; Huber C; Theobald M; Schuler M
    Cancer Res; 2008 May; 68(10):3899-906. PubMed ID: 18483275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
    J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
    Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
    Anticancer Res; 2003; 23(3B):2481-7. PubMed ID: 12894531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of cisplatin on the expression of Pokemon gene: experiment with different human lung cancer cells].
    Zhao ZH; Wang SF; Yu L; Wang J; Cong DG; Chang H; Wang XF; Zhang TW; Zhang J; Fu K; Jiang JY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1211-3. PubMed ID: 18844119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination effect of caffeine and cisplatin on a cisplatin resistant human lung cancer cell line].
    Ohsaki Y; Ishida S; Fujikane T; Akiba Y; Osanai S; Onodera S
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1339-43. PubMed ID: 2369137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.